Could gilteritinib keep AML in remission longer after transplant?
Knowledge-focused
Completed
This study looked at people with a type of leukemia (AML) that has a FLT3 gene change, which makes the cancer grow faster. After a stem cell transplant, some patients took the drug gilteritinib in earlier trials, while others received standard care. Researchers compared medical r…
Sponsor: Astellas Pharma Singapore Pte. Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:35 UTC